Mind Medicine (also often recognized as MindMed) was the primary psychedelic drugmaker to conduct an preliminary public offering (IPO), on Canada’s NEO Exchange in March 2020. The firm had been based lower than a year earlier, in May 2019. The drugmaker is presently conducting two section three studies evaluating COMP360 in treatment-resistant despair. Resul...
JeanetteN82's profile
JeanetteN82
1 month
